ABIVAX Société Anonyme ABVX
Set alert
89.41 USD +4.50 +5.30%
As of Nov 3, 11:17 AM ET
85.26 Day range 90.12
69.81 52-week range 148.83
- YTD
- -33.70%
- 1 year
- -9.55%
- Open
- 85.30
- Prev close
- 84.91
- Mkt cap
- 7.83B
- Vol
- 328.39K
- Avg vol
- 1.09M
- EPS
- -6.08
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 85.26
- High
- 90.12
- Forward P/E
- -22.14
- Beta
- -0.34
- Short ratio
- 5.08
- Inst. own
- 72.29%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Dec 21, 2026
- 50-d avg
- 100.14
- 200-d avg
- 114.10
- 1y target
- 163.58
1Y chart
Events in this range
- Dec 15, 2025Earnings: -2.4717; estimate -0.78649; surprise -214.27%
- Mar 23, 2026Earnings: -1.19; estimate -1.7; surprise 30%
- May 22, 2026Earnings: -0.71; estimate -1.07; surprise 33.64%
- Sep 10, 2026Rating: Goldman Sachs · — → Buy
- Sep 21, 2026Earnings: -1.71; estimate -0.97553; surprise -75.29%
- Sep 22, 2026Rating: Barclays · Overweight → Overweight
- Sep 22, 2026Rating: Wedbush · Neutral → Neutral
- Sep 22, 2026Rating: Truist Securities · Buy → Buy
- Oct 20, 2026Rating: Guggenheim · Buy → Buy
- Oct 21, 2026Rating: Wedbush · Neutral → Neutral
Signals (55)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 14, 2026 | 2 weeks ago |
| RSI: Oversold | Oct 7, 2026 | 3 weeks ago |
| RSI: Oversold | Sep 23, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 15, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 8, 2026 | 1 month ago |
| SMA: Bearish | Aug 20, 2026 | 2 months ago |
| SMA: Bearish | Aug 18, 2026 | 2 months ago |
| SMA: Bullish | Aug 17, 2026 | 2 months ago |
| SMA: Bearish | Aug 14, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 21, 2026 | 3 months ago |
| RSI: Overbought | Jul 2, 2026 | 4 months ago |
| SMA: Bullish | Jun 30, 2026 | 4 months ago |
| SMA: Bullish | Jun 30, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 29, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 24, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 23, 2026 | 4 months ago |
| SMA: Bearish | Jun 2, 2026 | 5 months ago |
| SMA: Bearish | Jun 2, 2026 | 5 months ago |
| MACD: Sell Signal | Jun 2, 2026 | 5 months ago |
| RSI: Oversold | Jun 2, 2026 | 5 months ago |
Newest 20 of 55.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 163.58 +83.0% upside
Now 89.41
- Target (low)
- 142.00
- Target (mean)
- 163.58
- Target (high)
- 181.00
Ratings (0m) 12 12 buy · 0 hold · 0 sell
- Strong buy4
- Buy8
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 12
- 1 month ago 12
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.85675 | -1.11 – -0.595 | -2.47 | +65.3% | 676.44K | -66.9% | 4 |
| Next quarter | -0.89425 | -1.16 – -0.639 | -1.18 | +24.3% | 686.03K | +46.0% | 4 |
| Current year | -4.17 | -4.67 – -3.81 | -5.59 | +25.4% | 4.00M | -13.0% | 7 |
| Next year | -3.84 | -4.91 – -2.52 | -4.17 | +8.1% | 71.87M | +1695.5% | 7 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 21, 2026 | Wedbush | Maintained | Neutral | Neutral |
| Oct 20, 2026 | Guggenheim | Reiterated | Buy | Buy |
| Sep 22, 2026 | Truist Securities | Maintained | Buy | Buy |
| Sep 22, 2026 | Wedbush | Maintained | Neutral | Neutral |
| Sep 22, 2026 | Barclays | Maintained | Overweight | Overweight |
| Sep 10, 2026 | Goldman Sachs | Initiated | — | Buy |
| Sep 5, 2026 | BTIG | Reiterated | Buy | Buy |
| Jul 9, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Jul 2, 2026 | Truist Securities | Maintained | Buy | Buy |
| Jul 1, 2026 | Citizens | Reiterated | Market Outperform | Market Outperform |
| Jun 30, 2026 | Jefferies | Upgrade | Hold | Buy |
| Jun 30, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
| Jun 30, 2026 | Wedbush | Maintained | Neutral | Neutral |
| Jun 30, 2026 | BTIG | Maintained | Buy | Buy |
| Jun 16, 2026 | BTIG | Reiterated | Buy | Buy |
| Jun 2, 2026 | Truist Securities | Maintained | Buy | Buy |
| Jun 2, 2026 | Jefferies | Downgrade | Buy | Hold |
| Jun 2, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jun 2, 2026 | Wedbush | Upgrade | Underperform | Neutral |
| Jun 2, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Jun 2, 2026 | BTIG | Reiterated | Buy | Buy |
| May 26, 2026 | Citizens | Reiterated | Market Outperform | Market Outperform |
| Mar 24, 2026 | Barclays | Maintained | Overweight | Overweight |
| Mar 16, 2026 | Jefferies | Initiated | — | Buy |
| Feb 25, 2026 | BTIG | Reiterated | Buy | Buy |
| Feb 24, 2026 | Wedbush | Initiated | — | Underperform |
| Jan 9, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jan 8, 2026 | BTIG | Maintained | Buy | Buy |
| Dec 16, 2025 | Citizens | Maintained | Market Outperform | Market Outperform |
| Nov 24, 2025 | Truist Securities | Initiated | — | Buy |